Molecular Testing in Thyroid Cancer
0 Visualizzazioni
• 07/01/23
0
0
Incorporare
administrator
Iscritti
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti